News Lilly sues over 'illegal sales' of obesity drug retatrutide Eli Lilly has sued six US-based companies it accuses of participating in an illegal black market for experimental weight-loss drug retatrutide.
News Another 340B lawsuit gets underway, in Illinois Three pharma groups have opened a new front in their legal challenge to the federal 340B drug pricing programme in the US.
News Novo Nordisk wins Netherlands GLP-1 compounding lawsuit A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide.
News Sandoz will pay another $480m to settle US antitrust suits Sandoz has reached a settlement in the US that, if approved, could lay to rest years of litigation over price-fixing of generic medicines.
News Lawmakers seek answers from RFK on Gardasil shot settlement Four Democratic senators are investigating whether the family of HHS Secretary RFK Jr is profiting from what they assert are "bogus" vaccine lawsuits.
News US judge says Novo Nordisk must face lawsuit over CagriSema A US judge has ruled that Novo Nordisk must face a lawsuit claiming it defrauded investors with misleading statements about a pivotal CagriSema study.
News ESC26: Isomab safety evidence on blood vessel growth for CAD Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.